REPL peer analysis
Replimune (REPL) against its competitors: price, today's move, 1-year return and market value side by side.
REPL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADAG Adagene | $2.51 | -6.34% | 30.73% | – |
| AGEN Agenus | $6.84 | -3.53% | 79.53% | $308.91M |
| CGEN Compugen | $1.98 | -2.94% | 20.00% | $187.56M |
| CTMX CytomX Therapeutics | $2.34 | 2.18% | -29.73% | $509.88M |
| IBRX ImmunityBio | $7.99 | -3.62% | 238.56% | $8.79B |
| IOVA Iovance | $8.00 | -5.66% | 310.26% | $3.84B |
| JANX Janux | $17.47 | 0.00% | -38.72% | – |
| LYEL Lyell Immunopharma | $11.04 | -2.34% | -33.21% | – |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| NRIX Nurix Therapeutics | $25.70 | -4.09% | 101.13% | – |
| REPL Replimune | $19.49 | 10.68% | 90.89% | $1.67B |
- REPL's peers: ADAG (Adagene), AGEN (Agenus), CGEN (Compugen), CTMX (CytomX Therapeutics), IBRX (ImmunityBio), IOVA (Iovance), JANX (Janux), LYEL (Lyell Immunopharma).
Updated 2026-11-03 00:02 UTC